Related Experiment Videos
Clinical and biochemical aspects of trichopoliodystrophy
Insights
Trichopoliodystrophy, a disease affecting copper metabolism, can manifest in utero with neurological and hair abnormalities. Early copper therapy may normalize levels but doesn't reverse severe neurological deficits.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Neurology
Background:
- Trichopoliodystrophy is a rare genetic disorder characterized by progressive neurological deterioration.
- A selective abnormality in copper metabolism is implicated in the disease's pathogenesis.
- Early diagnosis and intervention are crucial for managing metabolic disorders.
Purpose of the Study:
- To investigate the clinical and biochemical features of trichopoliodystrophy.
- To determine the onset and progression of the disease.
- To evaluate the efficacy of copper therapy.
Main Methods:
- Clinical evaluation of 6 patients with trichopoliodystrophy.
- Biochemical analysis of copper and ceruloplasmin levels in blood, liver, urine, and brain tissue.
- Assessment of neurological signs and hair abnormalities.
- Monitoring response to parenteral copper therapy.
Main Results:
- The disease can begin in utero, presenting with neurological and hair abnormalities at birth.
- Patients exhibited altered copper metabolism, including decreased hepatic copper and increased urinary excretion.
- Progressive neurological dysfunction was observed in all patients, with 4 deaths occurring between 2.5 months and 5.5 years.
- Copper therapy normalized blood and hepatic copper but did not correct significantly decreased copper levels in the cerebral cortex and white matter.
Conclusions:
- Trichopoliodystrophy is linked to a selective defect in copper metabolism, with potential in utero onset.
- Early detection of neurological and biochemical abnormalities is vital.
- While copper therapy can correct systemic copper levels, its impact on established neurological deficits, particularly in the central nervous system, requires further investigation.
Abstract:
The clinical and biochemical evaluation of 6 patients with trichopoliodystrophy indicates that the disease process can begin in utero and is related to a selective abnormality in copper metabolism. Examination of 2 infants on the first day of life revealed abnormal neurological signs, a characteristic hair abnormality, and elevated levels of copper and ceruloplasmin. Decreased hepatic copper levels and increased urinary copper excretion were documented during the first week. The 2 neonates demonstrated a progressive decrease in blood copper levels in the first month of life. Four infants identified at ages 2 to 11 months had low values for blood copper and ceruloplasmin. All infants had progressive neurological dysfunction, and 4 of the 6 died at ages ranging from 2 1/2 months to 5 1/2 years. Parenteral copper therapy achieved normal blood and hepatic copper levels in 1 patient, but the copper values in the cerebral cortex and white matter were significantly decreased compared to control specimens.